Search research articles
Contact Us
Filters
Showing results (181-190 of 536) with videos related to
Page
of 54
Sort By:
Journal of Hematology & Oncology
|
April 27, 2021
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
Ralf Buettner, Le Xuan Truong Nguyen, Corey Morales, et al.
International Journal of Pharmaceutics
|
September 10, 2008
A novel liposomal formulation of flavopiridol
Xiaojuan Yang, Xiaobin Zhao, Mitch A Phelps, et al.
Leukemia & Lymphoma
|
August 19, 2024
The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia
Dat Ngo, Jose Tinajero, Joo Y Song, et al.
British Journal of Haematology
|
April 1, 2024
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer
Hoda Pourhassan, Jianying Zhang, Jose Tinajero, et al.
Nature Communications
|
January 24, 2025
NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity
Rui Ma, Zhenlong Li, Hejun Tang, et al.
British Journal of Haematology
|
November 6, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomes
Jose Tinajero, Sharon Xu, Dat Ngo, et al.
Annals of Clinical and Translational Neurology
|
August 30, 2023
Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression
Lucas Vu, Krystine Garcia-Mansfield, Antonio Pompeiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies
Yicheng Mao, Georgia Triantafillou, Erin Hertlein, et al.
American Journal of Hematology
|
September 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden
Jose Tinajero, Kim Nguyen, Dat Ngo, et al.
Oncotarget
|
October 8, 2016
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma
Atish Mohanty, Natalie Sandoval, Manasi Das, et al.
Page
of 54
Search research articles
Search
Showing results (181-190 of 536) with videos related to
Sort By:
Page
of 54
Journal of Hematology & Oncology
|
April 27, 2021
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
Ralf Buettner, Le Xuan Truong Nguyen, Corey Morales, et al.
International Journal of Pharmaceutics
|
September 10, 2008
A novel liposomal formulation of flavopiridol
Xiaojuan Yang, Xiaobin Zhao, Mitch A Phelps, et al.
Leukemia & Lymphoma
|
August 19, 2024
The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia
Dat Ngo, Jose Tinajero, Joo Y Song, et al.
British Journal of Haematology
|
April 1, 2024
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer
Hoda Pourhassan, Jianying Zhang, Jose Tinajero, et al.
Nature Communications
|
January 24, 2025
NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity
Rui Ma, Zhenlong Li, Hejun Tang, et al.
British Journal of Haematology
|
November 6, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomes
Jose Tinajero, Sharon Xu, Dat Ngo, et al.
Annals of Clinical and Translational Neurology
|
August 30, 2023
Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression
Lucas Vu, Krystine Garcia-Mansfield, Antonio Pompeiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies
Yicheng Mao, Georgia Triantafillou, Erin Hertlein, et al.
American Journal of Hematology
|
September 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden
Jose Tinajero, Kim Nguyen, Dat Ngo, et al.
Oncotarget
|
October 8, 2016
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma
Atish Mohanty, Natalie Sandoval, Manasi Das, et al.
Page
of 54